Loading data
ORMPNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 2 m USD | — | 1.34 m USD | 2.7 m USD |
| Cost of revenue | 1.99 m USD | — | — | — |
| Gross profit | 13 k USD | — | — | — |
| Research and development expense | 6.38 m USD | 6.32 m USD | 8.97 m USD | 27.64 m USD |
| Operating profit | -15.09 m USD | -12.78 m USD | -15.77 m USD | -40.6 m USD |
| Interest expense | — | — | 2.04 m USD | — |
| Profit before tax | 75.32 m USD | -15.92 m USD | 5.09 m USD | -37.66 m USD |
| Income tax expense | 11.31 m USD | 3.18 m USD | — | 100 k USD |
| Net income (reported basis) | 75.32 k USD | -15.92 k USD | 5.09 k USD | -37.76 k USD |
| Net income attributable to common shareholders | 63.24 m USD | -19.06 m USD | — | -36.56 m USD |
| Basic earnings per share | 1.53 USD/share | -0.48 USD/share | 0.14 USD/share | -0.94 USD/share |
| Diluted earnings per share | 1.5 USD/share | -0.48 USD/share | 0.14 USD/share | -0.94 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.